Royal Bank of Canada
COYA icon

Royal Bank of Canada’s Coya Therapeutics COYA Stock Holding History

Royal Bank of Canada’s Portfolio COYA Stock Details COYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$546K Buy
93,414
+80,022
+598% +$371K ﹤0.01% 4304
2026
Q1 		$53K Sell
13,392
-14,044
-51% -$65.7K ﹤0.01% 5460
2025
Q4 		$159K Sell
27,436
-7,947
-22% -$48.3K ﹤0.01% 4919
2025
Q3 		$202K Buy
35,383
+22,000
+164% +$134K ﹤0.01% 5091
2025
Q2 		$77K Sell
13,383
-7,269
-35% -$42.1K ﹤0.01% 5737
2025
Q1 		$134K Sell
20,652
-2,000
-9% -$12.7K ﹤0.01% 5005
2024
Q4 		$130K Sell
22,652
-250
-1% -$1.7K ﹤0.01% 5166
2024
Q3 		$148K Sell
22,902
-10,796
-32% -$68.1K ﹤0.01% 5053
2024
Q2 		$204K Buy
33,698
+2,241
+7% +$18K ﹤0.01% 4752
2024
Q1 		$312K Buy
31,457
+31,248
+14,951% +$245K ﹤0.01% 4314
2023
Q4 		$2K Buy
209
+108
+107% +$599 ﹤0.01% 6791
2023
Q3 		$0 Sell
101
-51
-34% -$203 ﹤0.01% 7144
2023
Q2 		$1K Buy
+152
New +$705 ﹤0.01% 6979

Other funds holding COYA

DCM
DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

Royal Bank of Canada's COYA Position: Q2 2026 in Review

Royal Bank of Canada increased its Coya Therapeutics (COYA) stake by 598% in Q2 2026, buying an estimated $371K and bringing the position to 93,414 shares worth $546K. The position accounts for ﹤0.01% of the portfolio, ranked #4304.

Royal Bank of Canada first reported a position in COYA in Q2 2023 and has held it in 13 quarters since. 54 funds tracked by Wall St. Rank hold COYA as of Q2 2026.

  • Royal Bank of Canada held 93,414 shares of Coya Therapeutics worth $546K as of Q2 2026.
  • Royal Bank of Canada bought 80,022 Coya Therapeutics shares in Q2 2026, an estimated $371K.
  • Coya Therapeutics made up ﹤0.01% of Royal Bank of Canada's portfolio in Q2 2026, its #4304 holding.
  • Royal Bank of Canada first reported a position in Coya Therapeutics in Q2 2023 and has held it in 13 quarters since.
  • 54 funds tracked by Wall St. Rank held Coya Therapeutics as of Q2 2026.

Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.